Invalidity dossier

US 5323907

Child resistant package assembly for dispensing pharmaceutical medications

Current assignee: Multi Comp Inc

Added 9/23/2026, 9:02:32 PM

At a glanceNo PTAB challengesNo litigation on file

Active provider: DeepSeek · deepseek-flash

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

Patent Overview — US 5,323,907 A

Title: "Child resistant package assembly for dispensing pharmaceutical medications"

Key bibliographic data (from supplied source):

  • Patent number: US 5,323,907 A
  • Application number: US 08/031,657
  • Inventor: John D. Kalvelage
  • Original assignee / current assignee (as listed): Multi Comp Inc
  • Priority date: 1992-06-23
  • Filing date: 1993-03-15
  • Publication (grant) date: 1994-06-28
  • Anticipated expiration: 2012-06-23; status listed as "Expired – Lifetime"

Purpose: The patent addresses a recognized tension in pharmaceutical packaging: child-resistant packages are often difficult for adults—particularly elderly patients or those with limited dexterity—to open, risking that patients skip medication. The stated aim is a package that is child resistant yet accessible and user-friendly to adults, and that permits customized prescription packaging handled economically by a pharmacist.

Plain-language scope (from the described embodiments): The assembly has two main parts. (1) A blister package: a clear thermoformed plastic blister sheet (e.g., polyvinyl chloride or polyethylene terephthalate) with recesses holding capsules or tablets, covered by a lidding/backing sheet. (2) A surrounding molded plastic frame: two panels joined by a flexible integral hinge, folded face-to-face to sandwich the blister package. Both panels have correspondingly arranged apertures; the second panel's apertures partially obstruct those of the first, acting as a protective device that impedes unwanted removal of medication in child-resistant fashion. Features described include different panel configurations for capsules versus tablets, non-uniform blister thickness (thick on the press side, thin on the pinch side), locating bumps, an identifying alphanumeric grid, and optional score lines for separating individual blisters. Child-resistance involves successive actions (per the B65D2215/04 classification noted in the source).

Source: https://patents.google.com/patent/US5323907/en

What the excerpt does not establish: It does not provide the full claim text, the complete specification, or the drawings' details; it does not identify prior-art references or compare the invention to them; it does not address litigation, validity, enforceability, or the accuracy of the listed assignments (the source itself notes assignee/legal-status listings are assumptions, not legal conclusions). The omitted portion of the specification (noted in the source as excerpted) may contain additional details not summarized here.

Generated 10/1/2026, 9:41:01 PM

Cases on file (0)

Specific litigation cases in our database that name US patent 5323907. The free-form analysis below may also discuss cases beyond this list.

No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Log in to generate
Not generated yet. Log in to request this analysis.

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Log in to generate
Not generated yet. Log in to request this analysis.

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Log in to generate
Not generated yet. Log in to request this analysis.

Prior art

Earlier patents, publications, and products that may anticipate or render the claims unpatentable.

Log in to generate
Not generated yet. Log in to request this analysis.

Obviousness

Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.

Log in to generate
Not generated yet. Log in to request this analysis.

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Log in to generate
Not generated yet. Log in to request this analysis.

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

Log in to generate
Not generated yet. Log in to request this analysis.